We are live on
!
Find out more
DGM
Darwin Global Management Portfolio holdings
AUM
$3.77B
1-Year Est. Return
307.72%
This Fund
S&P 500
This Quarter
Est. Return
+35.85%
1 Year Est. Return
+307.72%
3 Year Est. Return
+2,873.14%
5 Year Est. Return
+48,315.58%
10 Year Est. Return
–
AUM
$2.38B
AUM Growth
+$920M
(+63%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
14.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
3
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insmed
INSM
|
+$302M |
| 2 |
MRUS
Merus
MRUS
|
+$18.6M |
| 3 |
CDTX
Cidara Therapeutics
CDTX
|
+$18.5M |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$15.3M |
| 5 |
Allogene Therapeutics
ALLO
|
+$39.9K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
VVP
ABC
SCA
ACH
GL
VA
GCC
SB
Darwin Global Management's Q2 2025 Portfolio in Review
As of Q2 2025, Darwin Global Management held 5 positions worth $2.38B, up 63% from $1.46B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Darwin Global Management deployed $354M of net new capital in Q2 2025, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Merus: 395,738 shares worth $21M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Darwin Global Management's largest Q2 2025 buy was Merus: 395,738 shares worth $21M.
- Darwin Global Management added most to Insmed in Q2 2025, an estimated $302M increase.
- Darwin Global Management's ten largest holdings make up 100% of its $2.38B portfolio in Q2 2025.
- Darwin Global Management opened 2 new positions and closed 0 in Q2 2025.
- Darwin Global Management's portfolio value rose 63% quarter-over-quarter to $2.38B.
Based on Darwin Global Management's 13F filing for Q2 2025, filed 14 Aug 2025.